These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
564 related items for PubMed ID: 32031203
1. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression. Li H, Tong L, Tao H, Liu Z. Biosci Rep; 2020 Feb 28; 40(2):. PubMed ID: 32031203 [Abstract] [Full Text] [Related]
2. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Yang D, He Y, Wu B, Liu R, Wang N, Wang T, Luo Y, Li Y, Liu Y. Cancer Biomark; 2020 Feb 28; 29(3):399-416. PubMed ID: 32741804 [Abstract] [Full Text] [Related]
3. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases. Yu Y, Tian X. Medicine (Baltimore); 2020 May 28; 99(19):e20183. PubMed ID: 32384511 [Abstract] [Full Text] [Related]
4. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma. Huo C, Zhang MY, Li R, Zhou XJ, Liu TT, Li JP, Liu X, Qu YQ. Int J Med Sci; 2020 May 28; 17(16):2427-2439. PubMed ID: 33029085 [Abstract] [Full Text] [Related]
5. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma. Yang Y, Wang M, Liu B. J Cell Physiol; 2019 Apr 28; 234(4):4454-4459. PubMed ID: 30317601 [Abstract] [Full Text] [Related]
10. Multiomics analysis on DNA methylation and the expression of both messenger RNA and microRNA in lung adenocarcinoma. Yang Z, Liu B, Lin T, Zhang Y, Zhang L, Wang M. J Cell Physiol; 2019 May 28; 234(5):7579-7586. PubMed ID: 30370535 [Abstract] [Full Text] [Related]
13. A methylation-related lncRNA-based prediction model in lung adenocarcinomas. Yang K, Liu H, Li JH. Clin Respir J; 2024 Aug 28; 18(8):e13753. PubMed ID: 39187946 [Abstract] [Full Text] [Related]
14. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis. Wang Y, Zhou Z, Chen L, Li Y, Zhou Z, Chu X. Mol Cell Biochem; 2021 Feb 28; 476(2):931-939. PubMed ID: 33130972 [Abstract] [Full Text] [Related]
15. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers. Li R, Yang YE, Yin YH, Zhang MY, Li H, Qu YQ. J Transl Med; 2019 Sep 27; 17(1):324. PubMed ID: 31558162 [Abstract] [Full Text] [Related]
19. Decreased HLF Expression Predicts Poor Survival in Lung Adenocarcinoma. Wang Z, Li X, Chen H, Han L, Ji X, Wang Q, Wei L, Miao Y, Wang J, Mao J, Zhang Z. Med Sci Monit; 2021 May 12; 27():e929333. PubMed ID: 33979320 [Abstract] [Full Text] [Related]
20. Genome-wide analysis of methylation CpG sites in gene promoters identified four pairs of CpGs-mRNAs associated with lung adenocarcinoma prognosis. Pan X, Ji P, Deng X, Chen L, Wang W, Li Z. Gene; 2022 Feb 05; 810():146054. PubMed ID: 34737001 [Abstract] [Full Text] [Related] Page: [Next] [New Search]